Page 38 - Roche Diagnostics News Today

The Elecsys beta-amyloid (1-42) CSF II and Elecsys phospho-tau (181P) CSF assays are for use in adults aged 55 and older who are being evaluated for cognitive difficulties.

First IVD company in the Middle East to achieve this prestigious certification in record timeBuilding trust with partners with exemplary protection of patient data informationDUBAI, UAE, Dec.

Report Description: HIV/AIDS Diagnostics Market – Growth, Future Prospects, and Competitive Analysis, 2017 – 2025, the global HIV/AIDS diagnostics market was valued at US$ 3,790.2 Mn in 2016, and is expected to reach US$ 8.718.8 Mn by 2025, expanding at a CAGR of 9.4% from 2017 to 2025. Browse Full Report Here: http://www.acutemarketreports.com/report/hiv-aids-diagnostics-market Market Insights There are around 36.7 million people suffering from HIV infection in 2015 (WHO studies). ...

Read about executive hires across healthcare and life sciences.

/PRNewswire/ -- Praava Health, Bangladeshs fastest-growing healthcare brand, recently announced the addition of four new members to its Global Advisory...

Roche (OTCQX:RHHBY)  announced today that it appointed Brad Moore as president and CEO of Roche Diagnostics North America.

/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the appointment of Brad Moore as president and CEO of Roche Diagnostics North America,...

/PRNewswire/ -- The "Personalized Medicine Market, Size, Share, Forecast 2023-2027, Industry Trends, Growth, Insight, Impact of Inflation, Company Analysis"...

/PRNewswire/ -- The "China Biopsy Market, Volume, Size, Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report...

/PRNewswire/ -- The "Europe Biopsy Devices Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis"...